Literature DB >> 12211895

Contrary to BCG, MLM fails to induce the production of TNF alpha and NO by macrophages.

Oscar Rojas-Espinosa1, Kendy Wek-Rodríguez, Patricia Arce-Paredes, Fabiola Aguilar-Torrentera, Carine Truyens, Yves Carlier.   

Abstract

Pathogenic mycobacteria must possess efficient survival mechanisms to resist the harsh conditions of the intraphagosomal milieu. In this sense, Mycobacterium lepraemurium (MLM) is one of the most evolved intracellular parasites of murine macrophages; this microorganism has developed a series of properties that allows it not only to resist, but also to multiply within the inhospitable environment of the phagolysosome. Inside the macrophages, MLM appears surrounded by a thick lipid-envelope that protects the microorganism from the digestive effect of the phagosomal hydrolases and the acid pH. MLM produces a disease in which the loss of specific cell-mediated immunity ensues, thus preventing activation of macrophages. In vitro, and possibly also in vivo, MLM infects macrophages without triggering the oxidative (respiratory burst) response of these cells, thus preventing the production of the toxic reactive oxygen intermediaries (ROI). Supporting the idea that MLM is within the most evolved pathogenic microorganisms, in the present study we found, that contrary to BCG, M. lepraemurium infects macrophages without stimulating these cells to produce meaningful levels of tumor necrosis factor alpha (TNF alpha) or nitric oxide (NO). Thus, the ability of the microorganisms to stimulate in their cellular hosts, the production of ROI and RNI (reactive nitrogen intermediates), seems to be an inverse correlate of their pathogenicity; the lesser their ability, the greater their pathogenicity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12211895

Source DB:  PubMed          Journal:  Int J Lepr Other Mycobact Dis        ISSN: 0148-916X


  5 in total

1.  Expression of cyclooxygenase-2, alpha 1-acid-glycoprotein and inducible nitric oxide synthase in the developing lesions of murine leprosy.

Authors:  Mayra Silva Miranda; Kendy Wek Rodríguez; Erasmo Martínez Cordero; Oscar Rojas-Espinosa
Journal:  Int J Exp Pathol       Date:  2006-12       Impact factor: 1.925

2.  Relative efficacy of uptake and presentation of Mycobacterium bovis BCG antigens by type I mouse lung epithelial cells and peritoneal macrophages.

Authors:  Mandavi Kumari; Rajiv K Saxena
Journal:  Infect Immun       Date:  2011-06-06       Impact factor: 3.441

3.  Induction and treatment of anergy in murine leprosy.

Authors:  Mario Juarez-Ortega; Víctor G Hernandez; Patricia Arce-Paredes; Enrique B Villanueva; Miguel Aguilar-Santelises; Oscar Rojas-Espinosa
Journal:  Int J Exp Pathol       Date:  2014-12-21       Impact factor: 1.925

4.  CD36 deficiency attenuates experimental mycobacterial infection.

Authors:  Michael Hawkes; Xiaoming Li; Maryanne Crockett; Angelina Diassiti; Constance Finney; Gundula Min-Oo; W Conrad Liles; Jun Liu; Kevin C Kain
Journal:  BMC Infect Dis       Date:  2010-10-15       Impact factor: 3.090

5.  Effect of reactive oxygen intermediaries on the viability and infectivity of Mycobacterium lepraemurium.

Authors:  Kendy Wek-Rodriguez; Mayra Silva-Miranda; Patricia Arce-Paredes; Oscar Rojas-Espinosa
Journal:  Int J Exp Pathol       Date:  2007-06       Impact factor: 1.925

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.